Standard

Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma. / Kolmakova, E. V.; Shulutko, B. I.; Shishkin, A. N.

в: Likars"ka sprava / Ministerstvo okhorony zdorov"ia Ukrainy, № 6, 01.06.1992, стр. 91-94.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Kolmakova, EV, Shulutko, BI & Shishkin, AN 1992, 'Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma', Likars"ka sprava / Ministerstvo okhorony zdorov"ia Ukrainy, № 6, стр. 91-94.

APA

Kolmakova, E. V., Shulutko, B. I., & Shishkin, A. N. (1992). Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma. Likars"ka sprava / Ministerstvo okhorony zdorov"ia Ukrainy, (6), 91-94.

Vancouver

Kolmakova EV, Shulutko BI, Shishkin AN. Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma. Likars"ka sprava / Ministerstvo okhorony zdorov"ia Ukrainy. 1992 Июнь 1;(6):91-94.

Author

Kolmakova, E. V. ; Shulutko, B. I. ; Shishkin, A. N. / Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma. в: Likars"ka sprava / Ministerstvo okhorony zdorov"ia Ukrainy. 1992 ; № 6. стр. 91-94.

BibTeX

@article{4e28a28ed3ac41df9a982fb7985b41ba,
title = "Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma",
abstract = "The nephrotic syndrome is characterized by proteinuria, hypoalbuminemia and hypercholesterolemia. Hypercholesterolemia is in some cases a risk factor for atherosclerosis in this group of patients. The lipid plasma spectrum was studied in 45 patients with the nephrotic syndrome. Most pronounced changes of the lipid composition of the plasma were revealed in patients with systemic lupus erythematosus and a special form of mesangio-proliferative glomerulonephritis which is characterized by a torpid course and rapid development of chronic renal failure. Plasma atherogenicity was calculated according to the index of plasma atherogenicity. A high atherogenicity index was revealed in patients with an association of the nephrotic syndrome and arterial hypertension. Plasma atherogenicity is determined mainly by the level of high-density-lipoprotein cholesterol.",
author = "Kolmakova, {E. V.} and Shulutko, {B. I.} and Shishkin, {A. N.}",
year = "1992",
month = jun,
day = "1",
language = "English",
pages = "91--94",
journal = " ЛIКАРСЬКА СПРАВА",
issn = "1019-5297",
publisher = "Zdorov'a",
number = "6",

}

RIS

TY - JOUR

T1 - Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma

AU - Kolmakova, E. V.

AU - Shulutko, B. I.

AU - Shishkin, A. N.

PY - 1992/6/1

Y1 - 1992/6/1

N2 - The nephrotic syndrome is characterized by proteinuria, hypoalbuminemia and hypercholesterolemia. Hypercholesterolemia is in some cases a risk factor for atherosclerosis in this group of patients. The lipid plasma spectrum was studied in 45 patients with the nephrotic syndrome. Most pronounced changes of the lipid composition of the plasma were revealed in patients with systemic lupus erythematosus and a special form of mesangio-proliferative glomerulonephritis which is characterized by a torpid course and rapid development of chronic renal failure. Plasma atherogenicity was calculated according to the index of plasma atherogenicity. A high atherogenicity index was revealed in patients with an association of the nephrotic syndrome and arterial hypertension. Plasma atherogenicity is determined mainly by the level of high-density-lipoprotein cholesterol.

AB - The nephrotic syndrome is characterized by proteinuria, hypoalbuminemia and hypercholesterolemia. Hypercholesterolemia is in some cases a risk factor for atherosclerosis in this group of patients. The lipid plasma spectrum was studied in 45 patients with the nephrotic syndrome. Most pronounced changes of the lipid composition of the plasma were revealed in patients with systemic lupus erythematosus and a special form of mesangio-proliferative glomerulonephritis which is characterized by a torpid course and rapid development of chronic renal failure. Plasma atherogenicity was calculated according to the index of plasma atherogenicity. A high atherogenicity index was revealed in patients with an association of the nephrotic syndrome and arterial hypertension. Plasma atherogenicity is determined mainly by the level of high-density-lipoprotein cholesterol.

UR - http://www.scopus.com/inward/record.url?scp=0026879688&partnerID=8YFLogxK

M3 - Article

C2 - 1455841

AN - SCOPUS:0026879688

SP - 91

EP - 94

JO - ЛIКАРСЬКА СПРАВА

JF - ЛIКАРСЬКА СПРАВА

SN - 1019-5297

IS - 6

ER -

ID: 126311260